Alcon

About the Company

• Alcon is an American global medical company specializing in eye care products
• Alcon is a subsidiary of Novartis Founded 1945
• Alcon was already the world's largest and most profitable eye care company when Novartis bought it
(completed in 2011), with 2009 annual sales of $6.5 billion and net income of $2 billion
• As the global leader in eye care, Alcon develops and manufactures innovative medicines and devices to Industry Ophthalmology
serve the full life cycle of eye care needs
CEO Mike Ball
Corporate Responsibility
Alcon is committed to providing education and training for eye care professionals around the world. Hünenberg,
Headquarters
From continuing education and sub-specialty training to panel discussions at key professional meetings, Switzerland
Alcon is building a support system for eye care today, along with a sustainable infrastructure for the
future No. of Employees 17,000+

Business Focus

• Alcon offers the industry’s most complete line of ophthalmic surgical products, enabling surgeons to achieve the best
results for their patients
Surgical
• Their surgical portfolio includes technologies and devices for cataract, retinal, glaucoma and refractive surgery, as well as
advanced technology intraocular lenses (ATIOLs) to treat cataracts and refractive errors, like presbyopia and astigmatism

• Through the integration of CIBA VISION, Alcon is now one of the largest manufacturers of contact lenses and lens care
products
Vision Care • Their Vision Care portfolio offers daily disposable, monthly replacement and color-enhancing contact lenses for
comfortable and convenient vision correction options
• They also have a complete line of contact lens care products

Mission & Vision

We have one mission: to discover new ways to enhance sight and improve people’s lives. Together with Novartis (link is
Mission external), we offer the widest spectrum of products in eye care. This enables us to serve our customers through the full life
cycle of patient needs across eye diseases, vision conditions and refractive errors.

Our vision is to be the most trusted leader in eye care. By serving and working with people worldwide, we are building our
Vision
reputation, while addressing the growing eye care demands of the future.

Relevant News
• Alcon DAILIES® contact lenses teams up with US Olympians – world-class gymnast Laurie Hernandez and soccer star Tobin Heath – to launch the
Invisible Edge campaign
• Alcon reported revenues of $1.52 billion for 2Q17, which was 1% higher YoY (year-over-year) than the $1.51 billion we saw in 2Q16

Questions

• What has been the effect of the new NPPA (National Pharmaceutical Pricing Authority) regulations by the government on the industry? How has
Novartis been affected?
• The Indian pharma industry is highly fragmented. What are some of the challenges you face and how does Alcon overcome them?
• Can you tell us about the incentivization and retention strategy for your frontline sales team? How do you ensure such an effective drug delivery
system?